Following the principle of 'Leading with Technology, Serving with Heart' Life Enhancement Technology Ltd. provides to the global market with high-tech medical devices with excellent quality and superior performance. Currently the company focuses its business in developing, manufacturing and marketing External Counter Pulsation (ECP) System, a non-invasive device for the treatment of cardiac diseases, such as angina and congestive heart failure (CHF), as well as other ischemic diseases.

Most employees at Life Enhancement Technology Ltd. have many years of experience in development, manufacturing and marketing of ECP systems. The company is in strict compliance with ISO13485/ISO9001 quality assurance systems as well as US FDA cGMP requirement, and is certified or approved by TUV Rheinland Group and US FDA. Life Enhancement Technology Ltd., in cooperation with Living Data Technology Corp. (a US company), has been well recognized globally for its design, manufacture, clinic study and after sale service of the state-of-the-art ECP system.

The CE Mark certified AngioNew/Heamagain ECP systems are also approved by the US FDA 510(K) clearance, and has been exported to the United States, the United Kingdom, India and Middle East countries.